Animalcare Group plc (AIM:ANCR)

Market Cap	229.92M +54.3%
Revenue (ttm)	81.07M +11.9%
Net Income	2.98M -83.8%
EPS	0.05 -85.1%
Shares Out	69.05M
PE Ratio	73.78
Forward PE	22.38
Dividend	0.05 (2.11%)
Ex-Dividend Date	n/a

Volume	640,878
Average Volume	112,674
Open	330.00
Previous Close	247.00
Day's Range	245.20 - 340.00
52-Week Range	216.00 - 340.00
Beta	0.49
RSI	81.51
Earnings Date	Mar 27, 2026

About Animalcare Group

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, Asia, the Middle East, Africa, European Union, and internationally. Animalcare Group plc is based in York, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Jennifer Ann Winter
• Employees: 201
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANCR

Financial Performance

In 2024, Animalcare Group's revenue was 74.23 million, an increase of 4.94% compared to the previous year's 70.73 million. Earnings were 18.49 million, an increase of 1442.45%.